What ingredients are in Joint Genesis?
Direct answer: the supplied Supplement Facts panel lists 200 mg ginger powder, 100 mg Boswellia serrata extract standardized to 65% boswellic acid, 80 mg hyaluronic acid matrix identified as Mobilee®, 150 mg Pinus pinaster pine bark extract, and 5 mg black pepper extract standardized to 95% piperine. Serving size is one capsule, with 30 servings per container.
These amounts are the controlling formula data for this project because they come from the supplied product label. Merchant prose, third-party reviews and promotional graphics should not override the label where they conflict.
Why does exact ingredient form matter?
Evidence is transferable only to the extent that ingredient identity, dose, standardization, route and population are comparable. A study on one botanical extract does not automatically validate every preparation from the same plant species. This is particularly important for pine bark. The Joint Genesis label says Pinus pinaster pine bark extract, 150 mg, but does not name Pycnogenol®. Research on Pycnogenol can be useful context for maritime pine bark biology, yet it is not direct evidence for the Joint Genesis ingredient.
Editorial rule: species similarity is not product equivalence. Where the label does not specify the studied branded extract, research is contextual rather than direct product support.
What does the ginger evidence add?
Ginger has independent human evidence relevant to osteoarthritis symptoms, but the Joint Genesis dose should not be assumed equivalent to studied preparations. Bartels and colleagues pooled five randomized placebo-controlled trials involving 593 adults and reported modest average reductions in pain and disability. Participants assigned to ginger were also more likely to discontinue because of adverse events. The authors judged the evidence moderate in quality.
For Joint Genesis, this means ginger belongs to an ingredient category with human research. It does not establish that the 200 mg powder dose shown on the label reproduces the pooled outcomes.
How strong is the Boswellia evidence?
Boswellia has a substantial clinical literature, but recent synthesis shows why selective positive quoting can be misleading. A 2024 systematic review and meta-analysis reported high heterogeneity and did not find significant pooled effects for some main WOMAC and VAS comparisons, although placebo subgroup analyses were favorable. The authors called for further high-quality studies.
Joint Genesis uses 100 mg of Boswellia extract standardized to 65% boswellic acid. That label specificity is useful, but the literature contains different extracts and dosing systems. The correct framing is evidence-connected ingredient with formulation-specific uncertainty.
What about piperine and safety?
The piperine-rich black pepper extract should not be presented merely as an absorption booster. A pharmacology review describes piperine as capable of influencing drug-metabolizing enzymes and transporters and potentially changing the pharmacokinetics of co-administered drugs. Clinical significance depends on dose, frequency, duration and the medication involved.
This does not establish that the 5 mg Joint Genesis dose will cause a meaningful interaction in every user. It does support a clear caution for medication users.
See the full safety review →
